The Antalgic Effect of Pulse Frequency and Pad Size of TENS on Blunt Pressure Pain

NCT ID: NCT01999595

Last Updated: 2021-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-01

Study Completion Date

2013-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the antalgic of surface electrical stimulation with pulse frequencies and pad sizes on blunting pressure pain on healthy human due to various temporal and spatial summations of the stimulation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Potential participants expressing interest in the study will be given to read the contraindications for the pain tests and the stimulation intervention, which has been documented on the consent form. All participants meeting entry requirements will be invited to participate in the experiments which take place on a separate occasion.

Each participant will sign the consent form and will be told again that they can withdraw from the study at any time and without explanation. Each participant will be required to experience a 10-minute pre-stimulation period, a 30 minute TENS intervention, a 30 minute follow-up period.

Participants will be seated on a chair with arm support provided by a side table. The investigator will be then informed the stimulation intervention and used pad size on the stimulation periods in written form contained in a sealed envelope. After the participant's verbal permission is obtained, the investigator will apply the pads on the dorsal forearm area.

Either the large size pad, 5cm x 10cm, or the small size,2.5cm x 2.5cm, will be choose to place on the dorsal side of the forearm to straddle the site for blunt pressure pain. The muscle bellies of the forearm are mainly located on the proximal half part. The proximal pad will be attached to the lateral epi-condyle of the elbow, and the distal electrode will be placed 3cm distal to the proximal one along the line between the lateral part of elbow and the mid-point of the wrist. The pads will be then connected to the intervention stimulator. The investigator will relay instructions to the participants using cue cards displayed 30 seconds before any required action.

Before each blunting pressure pain test, the participant will sit comfortably and place their right upper extremity on a side table with the shoulder abduction, elbow flexion, the forearm pronation. The test will be induced using a pressure algometer with a flat circular probe, measuring 1.1cm in diameter (1cm2 on skin surface). Force will be displayed digitally in increments of 0.1 Newton. The algometer will be applied to the mid-point between the intervention pads. The rate of the pressure algometer application will be around 6 Newtons per second on average. The participants will be asked to concentrate on the sensations in the forearm. When the pressure becomes definitely painful, the participant will state "Pain!" and the force will be stopped. The pain threshold will be taken twice in a minute for one test and each measurement will take no more than 30 seconds.

There will be seven 1-minute tests performed in this experiment. The first test in pre-stimulation period. The second and third tests were administered and started at 9, 19, 29 minute time points in the stimulation-on period. A 30 minute post stimulation period will be then followed. Another 3 tests will be performed in this period in ten-minute intervals at 39, 49, 59 minute time points after the stimulation start.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transcutaneous Electrical Nerve Stimulation Blunt Pressure Pain Pad Size Pulse Frequency Analgesia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

transcutaneous electrical nerve stimulation pad size pulse frequency blunt pressure pain healthy humans.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

One hundred eighty participants (equal number of females and males, Fig. 1) were randomly assigned into six groups with the following TENS characteristics. (1) Group 1:

control group, (2) group 2: sham group, (3) group 3: high frequency (80 pps)/large pad (5 cm x 10 cm) group, (4) group 4: low frequency (3 pps)/large pad (5 cm x 10 cm) group, (5) group 5: high frequency (80 pps)/small pad (5 cm x 2.5 cm) group, and (6) group 6: low frequency (3 pps)/small pad (5 cm x 2.5 cm) group.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators
The group allocation for each participant was sealed in an envelope prepared by an investigator. Just before the start of the second visit, a second investigator opened the envelope to confirm the allocation of TENS groups for individual participants and applied the TENS. For better blinding, a third investigator assessed the blunt pressure pain threshold (BPPT) for the baseline value.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High frequency TENS with large pads

TENS=transcutaneous electrical nerve stimulation

High frequency TENS was a 80 Hz TENS delivered via a pair of electrodes with the size of 5 cm x 10 cm

Dosage: same as electrical density using a standardized pad size (5cm x 5cm) with comfortable intensity

Group Type EXPERIMENTAL

High frequency TENS with large pads

Intervention Type DEVICE

High frequency TENS was delivered on large electrodes

Low frequency TENS with large pads

TENS=transcutaneous electrical nerve stimulation

Low frequency TENS was a 3 Hz TENS delivered via a pair of electrodes with the size of 5 cm x 10 cm

Dosage: same as electrical density using a standardized pad size (5cm x 5cm) with comfortable intensity

Group Type EXPERIMENTAL

Low frequency TENS with large pads

Intervention Type DEVICE

Low frequency TENS was delivered on large electrodes

High frequency TENS with small pads

TENS=transcutaneous electrical nerve stimulation

High frequency TENS was a 80 Hz TENS delivered via a pair of electrodes with the size of 5 cm x 2.5 cm

Dosage: same as electrical density using a standardized pad size (5cm x 5cm) with comfortable intensity

Group Type EXPERIMENTAL

High frequency TENS with small pads

Intervention Type DEVICE

High frequency TENS was delivered on small electrodes

Low frequency TENS with small pads

TENS=transcutaneous electrical nerve stimulation

Low frequency TENS was a 3 Hz TENS delivered via a pair of electrodes with the size of 5 cm x 2.5 cm

Dosage: same as electrical density using a standardized pad size (5cm x 5cm) with comfortable intensity

Group Type EXPERIMENTAL

Low frequency TENS with small pads

Intervention Type DEVICE

Low frequency TENS was delivered on small electrodes

Control TENS

TENS=transcutaneous electrical nerve stimulation

Control TENS was the application of electrical stimulation via skin with no current

Group Type PLACEBO_COMPARATOR

Control TENS

Intervention Type DEVICE

Control TENS was the application of electrical stimulation via skin with no current

Sham TENS

TENS=transcutaneous electrical nerve stimulation

Sham TENS was the application of electrical stimulation via skin with no current on the participant, who was told that the TENS was "turn-on" whether you feel it or not

Group Type SHAM_COMPARATOR

Sham TENS

Intervention Type DEVICE

Sham TENS was the application of electrical stimulation via skin with no current on the participant, who was told "TENS is at a turn-on level whether or not you feel it"

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control TENS

Control TENS was the application of electrical stimulation via skin with no current

Intervention Type DEVICE

Sham TENS

Sham TENS was the application of electrical stimulation via skin with no current on the participant, who was told "TENS is at a turn-on level whether or not you feel it"

Intervention Type DEVICE

High frequency TENS with large pads

High frequency TENS was delivered on large electrodes

Intervention Type DEVICE

Low frequency TENS with large pads

Low frequency TENS was delivered on large electrodes

Intervention Type DEVICE

High frequency TENS with small pads

High frequency TENS was delivered on small electrodes

Intervention Type DEVICE

Low frequency TENS with small pads

Low frequency TENS was delivered on small electrodes

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy and aged 18 years or over

Exclusion Criteria

* Any open wound around the arm or hand area, including edema or inflammation;
* Cardiac or vascular problems (such as coronary artery disease, coronary thrombosis, or angina pain, high blood pressures, phlebitis, and pacemaker implantation);
* Any dermatological problems or infections around the hand, forearm, or arm area (such as dermatitis or eczema, bacterial or fungal infections);
* Any history of neoplasm or malignancy;
* Bleeding diseases on the arm or hand (such as haemorrhage); Menstruation or pregnancy;
* Abnormal neurological signs in the upper limbs (such as altered skin sensations);
* Hypersensitivity or phobia to electrical application;
* Any current medication regime.
Minimum Eligible Age

18 Years

Maximum Eligible Age

26 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hung Kaung University

OTHER

Sponsor Role collaborator

Chang Gung University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chih Chung Chen

Assistant Professor in Department of Physical Therapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chih Chung Chen, D.Ph.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chang Gung University

Guishan, Taoyuan, Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

References

Explore related publications, articles, or registry entries linked to this study.

Chesterton LS, Foster NE, Wright CC, Baxter GD, Barlas P. Effects of TENS frequency, intensity and stimulation site parameter manipulation on pressure pain thresholds in healthy human subjects. Pain. 2003 Nov;106(1-2):73-80. doi: 10.1016/s0304-3959(03)00292-6.

Reference Type RESULT
PMID: 14581113 (View on PubMed)

Chesterton LS, Barlas P, Foster NE, Baxter DG, Wright CC. Gender differences in pressure pain threshold in healthy humans. Pain. 2003 Feb;101(3):259-266. doi: 10.1016/S0304-3959(02)00330-5.

Reference Type RESULT
PMID: 12583868 (View on PubMed)

Chesterton LS, Barlas P, Foster NE, Lundeberg T, Wright CC, Baxter GD. Sensory stimulation (TENS): effects of parameter manipulation on mechanical pain thresholds in healthy human subjects. Pain. 2002 Sep;99(1-2):253-62. doi: 10.1016/s0304-3959(02)00118-5.

Reference Type RESULT
PMID: 12237203 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HK-99-B-07

Identifier Type: OTHER

Identifier Source: secondary_id

102-4765B

Identifier Type: -

Identifier Source: org_study_id